Cargando…

Modulation of Gut Microbiota and Metabolites by Berberine in Treating Mice With Disturbances in Glucose and Lipid Metabolism

Introduction: Glucose and lipid metabolism disturbances has become the third major disease after cancer and cardio-cerebrovascular diseases. Emerging evidence shows that berberine can effectively intervene glucose and lipid metabolism disturbances, but the underlying mechanisms of this remain unclea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Xinyi, Wu, Haoran, Wang, Xinmiao, Lian, Fengmei, Li, Min, Miao, Runyu, Wei, Jiahua, Tian, Jiaxing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204213/ https://www.ncbi.nlm.nih.gov/pubmed/35721198 http://dx.doi.org/10.3389/fphar.2022.870407

Ejemplares similares

Research progress on the pharmacological effects of berberine targeting mitochondria
por: Fang, Xinyi, et al.
Publicado: (2022)

Efficacy and Mechanism of the Jiangtang Tiaozhi Recipe in the Management of Type 2 Diabetes and Dyslipidaemia: A Clinical Trial Protocol
por: Wu, Haoran, et al.
Publicado: (2022)

Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota
por: Yang, Sa, et al.
Publicado: (2022)

Gut Microbiota-Regulated Pharmacokinetics of Berberine and Active Metabolites in Beagle Dogs After Oral Administration
por: Feng, Ru, et al.
Publicado: (2018)

Akt: A Potential Drug Target for Metabolic Syndrome
por: Miao, Runyu, et al.
Publicado: (2022)

Gut Microbiota and Related Metabolites Were Disturbed in Ulcerative Colitis and Partly Restored After Mesalamine Treatment
por: Dai, Liang, et al.
Publicado: (2021)

Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota
por: Yang, Shengjie, et al.
Publicado: (2021)

Olanzapine-induced lipid disturbances: A potential mechanism through the gut microbiota-brain axis
por: Zhu, Zhenyu, et al.
Publicado: (2022)

Metformin modulates the gut microbiome in a mice model of high-fat diet-induced glycolipid metabolism disorder
por: Wu, Haoran, et al.
Publicado: (2022)

Berberine Regulates Treg/Th17 Balance to Treat Ulcerative Colitis Through Modulating the Gut Microbiota in the Colon
por: Cui, Huantian, et al.
Publicado: (2018)

Asparagus cochinchinensis alleviates disturbances of lipid metabolism and gut microbiota in high-fat diet-induced obesity mice
por: Luo, Shiyue, et al.
Publicado: (2022)

Advances in multi-omics study of biomarkers of glycolipid metabolism disorder
por: Fang, Xinyi, et al.
Publicado: (2022)

Pharmacokinetics and Excretion of Berberine and Its Nine Metabolites in Rats
por: Feng, Xinchi, et al.
Publicado: (2021)

Berberine Alleviates Non-alcoholic Steatohepatitis Through Modulating Gut Microbiota Mediated Intestinal FXR Activation
por: Shu, Xiangbing, et al.
Publicado: (2021)

Berberine-Loaded Carboxylmethyl Chitosan Nanoparticles Ameliorate DSS-Induced Colitis and Remodel Gut Microbiota in Mice
por: Zhao, Luqing, et al.
Publicado: (2021)

Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE−/− Mice
por: Wu, Min, et al.
Publicado: (2020)

Berberine Improves Glucose and Lipid Metabolism in HepG2 Cells Through AMPKα1 Activation
por: Ren, Gang, et al.
Publicado: (2020)

Combining fecal microbiome and metabolomics to reveal the disturbance of gut microbiota in liver injury and the therapeutic mechanism of shaoyao gancao decoction
por: Li, Jingwei, et al.
Publicado: (2022)

Characteristics of Serum Metabolites and Gut Microbiota in Diabetic Kidney Disease
por: Zhang, Bo, et al.
Publicado: (2022)

The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease
por: Zhang, Qing, et al.
Publicado: (2021)

Transformation of berberine to its demethylated metabolites by the CYP51 enzyme in the gut microbiota
por: Zhang, Zheng-Wei, et al.
Publicado: (2021)

Gut microbiota-derived metabolites in inflammatory diseases based on targeted metabolomics
por: Xu, Hui, et al.
Publicado: (2022)

PDX-1: A Promising Therapeutic Target to Reverse Diabetes
por: Zhang, Yanjiao, et al.
Publicado: (2022)

Disturbances of the Gut Microbiota and Microbiota-Derived Metabolites in Inflammatory Bowel Disease
por: Hu, Yongjia, et al.
Publicado: (2022)

The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease
por: Huang, Yinghui, et al.
Publicado: (2022)

Ginsenoside Rc ameliorated atherosclerosis via regulating gut microbiota and fecal metabolites
por: Xie, Bin, et al.
Publicado: (2022)

Therapeutic Effects of Berberine on Liver Fibrosis are associated With Lipid Metabolism and Intestinal Flora
por: Liu, Xianzhi, et al.
Publicado: (2022)

Efficacy and underlying mechanisms of berberine against lipid metabolic diseases: a review
por: Cai, Yajie, et al.
Publicado: (2023)

Stachyose Improves the Effects of Berberine on Glucose Metabolism by Regulating Intestinal Microbiota and Short-Chain Fatty Acids in Spontaneous Type 2 Diabetic KKAy Mice
por: Cao, Hui, et al.
Publicado: (2020)

Potential benefits of metformin and pioglitazone combination therapy via gut microbiota and metabolites in high-fat diet-fed mice
por: Wang, Dongmei, et al.
Publicado: (2022)

The Influence of Different Types of Diabetes on Vascular Complications
por: Wei, Jiahua, et al.
Publicado: (2022)

Plasma Metabolites and Gut Microbiota Are Associated With T cell Imbalance in BALB/c Model of Eosinophilic Asthma
por: Zhou, Yumei, et al.
Publicado: (2022)

Effects of Berberine on Atherosclerosis
por: Rui, Rui, et al.
Publicado: (2021)

Ferulic Acid Ameliorates Atherosclerotic Injury by Modulating Gut Microbiota and Lipid Metabolism
por: Gu, Yuyan, et al.
Publicado: (2021)

Gut microbiota and microbiota-derived metabolites in cardiovascular diseases
por: Chen, Xiaofeng, et al.
Publicado: (2023)

Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis
por: Xie, Wenting, et al.
Publicado: (2022)

Intra-Herb Interactions: Primary Metabolites in Coptidis Rhizoma Extract Improved the Pharmacokinetics of Oral Berberine Hydrochloride in Mice
por: Zhao, Jing, et al.
Publicado: (2021)

A New Therapeutic Candidate for Cardiovascular Diseases: Berberine
por: Cai, Yun, et al.
Publicado: (2021)

Role of Butyrate, a Gut Microbiota Derived Metabolite, in Cardiovascular Diseases: A comprehensive narrative review
por: Amiri, Parichehr, et al.
Publicado: (2022)

Cordyceps militaris extracts and cordycepin ameliorate type 2 diabetes mellitus by modulating the gut microbiota and metabolites
por: Liu, Xinyuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v8hkhhahg96nc2stib8ss2ljf0